The dental and medical clinicians of the Clinical/Laboratory Core will see all patients referred by the epidemiology cohorts and validate diagnoses. From these referrals and other sources of patient referrals, they will continue to build clinical cohorts of patients with specific oral lesions in order to analyze their relationship to the development of AIDS and to other markers/predictors. They will obtain samples and biopsies for the studies in Projects 4 and 5 from well-characterized patients with the oral lesions being studied. The core staff will be responsible for clinical research patient charts and records, for appointments, for follow-up calls concerning outcome, for specimen handling and storage and for getting specimens to Project 4 and 5 investigators. They will stain smears and sections, handle samples and biopsy tissue, maintain pathology and other clinical laboratory data, perform in situ hybridization for Epstein-Barr virus to confirm the diagnosis of hairy leukoplakia and provide electronmicroscopy services. The Clinical/Laboratory Core investigators will continue to study the clinical and pathological features of the oral manifestations of HIV infection and, in conjunction with Project 1, 4 and 5 investigators, will continue to report new features and to explore their etiology, pathogenesis and response to therapy. Part of the responsibilities of the investigators in the Cores and Projects will be to continue to document and publish such new findings and to conceive and test new hypotheses concerning this fascinating and challenging group of diseases.

Project Start
Project End
Budget Start
Budget End
Support Year
10
Fiscal Year
1996
Total Cost
Indirect Cost
Dollard, Sheila C; Butler, Lisa M; Jones, Alison M Graves et al. (2010) Substantial regional differences in human herpesvirus 8 seroprevalence in sub-Saharan Africa: insights on the origin of the ""Kaposi's sarcoma belt"". Int J Cancer 127:2395-401
Chang, W L William; Barry, Peter A; Szubin, Richard et al. (2009) Human cytomegalovirus suppresses type I interferon secretion by plasmacytoid dendritic cells through its interleukin 10 homolog. Virology 390:330-7
Sroussi, Herve Y; Köhler, Gerwald A; Agabian, Nina et al. (2009) Substitution of methionine 63 or 83 in S100A9 and cysteine 42 in S100A8 abrogate the antifungal activities of S100A8/A9: potential role for oxidative regulation. FEMS Immunol Med Microbiol 55:55-61
Szubin, Richard; Chang, W L William; Greasby, Tamara et al. (2008) Rigid interferon-alpha subtype responses of human plasmacytoid dendritic cells. J Interferon Cytokine Res 28:749-63
Chidzonga, Midion M; Mwale, Magda; Malvin, Kathy et al. (2008) Oral candidiasis as a marker of HIV disease progression among Zimbabwean women. J Acquir Immune Defic Syndr 47:579-84
Owotade, F J; Shiboski, C H; Poole, L et al. (2008) Prevalence of oral disease among adults with primary HIV infection. Oral Dis 14:497-9
Haas-Stapleton, Eric J; Lu, Yan; Hong, Song et al. (2007) Candida albicans modulates host defense by biosynthesizing the pro-resolving mediator resolvin E1. PLoS One 2:e1316
Tugizov, Sharof; Herrera, Rossana; Veluppillai, Piri et al. (2007) Epstein-Barr virus (EBV)-infected monocytes facilitate dissemination of EBV within the oral mucosal epithelium. J Virol 81:5484-96
Palefsky, J (2006) Biology of HPV in HIV infection. Adv Dent Res 19:99-105
Sroussi, H Y; Berline, J; Dazin, P et al. (2006) S100A8 triggers oxidation-sensitive repulsion of neutrophils. J Dent Res 85:829-33

Showing the most recent 10 out of 124 publications